Diabetes Care, 40 (12), 18361844
doi: 10.1080/08923973.2025.2482863 243 El-DessoukiAMYousefEHRaslanNAAlwakeelAIIbrahimSAlzokakyAA
The dosing protocol you choose should account for your individual tolerance
Benefits (Research Focus) Dual receptor agonism studied for simultaneous activation of GIP and GLP-1 receptors with imbalanced biased agonism Glycemic control research investigated for fasting glucose, HbA1c, and insulin sensitivity parameters in T2D models Body composition examined for fat-mass and lean-mass partitioning in obesity models Gastric emptying explored for delayed gastric transit and downstream satiety endpoints Long-acting profile C20 fatty diacid albumin-binding chemistry for extended half-life (~5 days) What Researchers Look At Receptor binding affinity and selectivity at GIPR vs GLP-1R cAMP and -arrestin recruitment in cell lines expressing each receptor subtype Food intake, body weight, and adipose-tissue change in DIO rodent models Gastric emptying time and gastrointestinal transit profiles Comparative pharmacology versus semaglutide, retatrutide, and other incretin analogs Quick Specs Form: Lyophilized white powder Net Peptide Content: 10 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: Tirzepatide Synonyms: LY3298176
If vitamin B12 support is recommended, your care plan may be tailored based on factors such as: Your medical history Current symptoms Dietary patterns Prior lab work Overall wellness goals Provider assessment Any recommendation is made on an individual basis after consultation
These effects have been observed across multiple agents, including semaglutide, liraglutide, and dulaglutide
